Suraksha Diagnostic Intrinsic Value

Suraksha Diagnostic (SURAKSHA) median intrinsic value is ₹210.00 from 9 valuation models (range ₹76–₹631), vs current price ₹252.30 — -16.8% downside (Trading Above Median Value), margin of safety -20.1%. For current market price and key ratios, visit Suraksha Diagnostic share price screener.

Current Stock Price
₹252.30
Primary Intrinsic Value
₹83.04
Market Cap
₹252.3 Cr
-16.8% Downside
Median Value
₹210.00
Value Range
₹76 - ₹631
Assessment
Trading Above Median Value
Safety Margin
-20.1%

SURAKSHA Valuation Methods Summary — DCF, Graham Number & P/E

Suraksha Diagnostic intrinsic value across 9 models vs current price ₹252.30 — upside/downside and value range per method. Analyse SURAKSHA shareholder distribution to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹83.04 ₹66.43 - ₹99.65 -67.1% EPS: ₹6.92, Sector P/E: 12x
Book Value Method asset ₹210.00 ₹189.00 - ₹231.00 -16.8% Book Value/Share: ₹210.00, P/B: 1.0x
Revenue Multiple Method revenue ₹256.00 ₹230.40 - ₹281.60 +1.5% Revenue/Share: ₹320.00, P/S: 0.8x
EBITDA Multiple Method earnings ₹504.60 ₹454.14 - ₹555.06 +100.0% EBITDA: ₹100.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹630.75 ₹504.60 - ₹756.90 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹75.69 ₹68.12 - ₹83.26 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹75.69 ₹68.12 - ₹83.26 -70.0% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹504.00 ₹453.60 - ₹554.40 +99.8% ROE: 17.1%, P/E Multiple: 14x
Graham Defensive Method conservative ₹180.82 ₹162.74 - ₹198.90 -28.3% EPS: ₹6.92, BVPS: ₹210.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

SURAKSHA Intrinsic Value vs Market Price — All Valuation Models

Suraksha Diagnostic fair value range ₹76–₹631 vs current market price ₹252.30 across 9 valuation models. Read SURAKSHA dividend growth for the complete payout history and dividend yield track record.

SURAKSHA Intrinsic Value Analysis — Undervalued or Overvalued?

Suraksha Diagnostic median intrinsic value ₹210.00, current price ₹252.30 — Trading Above Median Value by 16.8%, margin of safety -20.1%.

What is the intrinsic value of SURAKSHA?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Suraksha Diagnostic (SURAKSHA) is ₹210.00 (median value). With the current market price of ₹252.30, this represents a -16.8% variance from our estimated fair value.

The valuation range spans from ₹75.69 to ₹630.75, indicating ₹75.69 - ₹630.75.

Is SURAKSHA undervalued or overvalued?

Based on our multi-method analysis, Suraksha Diagnostic (SURAKSHA) appears to be trading above median value by approximately 16.8%.

SURAKSHA Financial Health — Key Ratios vs Industry Benchmarks

Suraksha Diagnostic financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.58 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Return on Equity 17.1% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 31.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.96x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

SURAKSHA Cash Flow Quality — Operating & Free Cash Flow

Suraksha Diagnostic operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹63 Cr ₹43 Cr Positive Free Cash Flow 8/10
March 2024 ₹61 Cr ₹44 Cr Positive Free Cash Flow 8/10
March 2023 ₹44 Cr ₹34 Cr Positive Free Cash Flow 8/10
March 2022 ₹42 Cr ₹20 Cr Positive Free Cash Flow 7/10
March 2021 ₹24 Cr ₹10 Cr Positive Free Cash Flow 7/10